Sudden Cardiac Arrest

Introduction

Sudden cardiac arrest (SCA) is a life-threatening medical emergency characterized by the abrupt cessation of the heart’s pumping function, leading to immediate loss of consciousness and collapse. This critical event is a significant public health challenge, responsible for the loss of over 300,000 individuals annually in the United States.^[1]

Biological Basis

The underlying biological mechanism of SCA primarily involves severe electrical disturbances in the heart, known as life-threatening arrhythmias, which prevent effective blood circulation. While a substantial proportion, approximately 80%, of individuals affected by SCA have underlying coronary artery disease.^[1] there is a well-established genetic contribution. Family history is a recognized risk factor for sudden cardiac death or cardiac arrest.^[2] with studies indicating a significant heritability, demonstrating relative risks of 1.5 to 2.^[3] Research has identified specific genetic variants and genomic loci associated with SCA. These include variations in cardiac ion channel genes such as _KCNQ1_ and _SCN5A_.^[4] as well as genetic variations in the nitric oxide synthase 1 adaptor protein (_NOS1AP_).^[5] Additionally, common variants across at least ten genomic loci have been correlated with QT duration, an important measure of cardiac repolarization.^[6]

Clinical Relevance

From a clinical perspective, understanding the genetic factors influencing SCA is essential for identifying at-risk individuals and guiding preventative or therapeutic strategies. QT duration, which reflects the time it takes for the heart’s ventricles to repolarize, serves as a key indicator of cardiac electrical activity.^[7] For individuals deemed at high risk, implantable cardioverter-defibrillators (ICDs) are a crucial intervention, with approximately 250,000 devices implanted each year in the United States.^[7]The criteria for ICD implantation typically include conditions such as diminished ejection fraction, symptomatic heart failure, and, to a lesser extent, prolongation of the QRS interval or other primary arrhythmogenic cardiomyopathies.^[7]

Social Importance

The high mortality rate associated with SCA underscores its profound social and economic impact. The devastating consequences for individuals and families, coupled with the significant burden on healthcare systems, highlight the urgent need for ongoing research into its causes and prevention. Genetic research provides a vital framework for improving arrhythmia therapy.^[3] and for identifying genetic determinants that can enhance risk prediction and inform preventative strategies.^[8] Advances in this field, including device genomics, offer promising avenues for better patient outcomes and addressing the broader challenges in healthcare.^[7]

Generalizability and Phenotypic Heterogeneity

Many genetic studies investigating sudden cardiac arrest and related cardiac traits primarily include individuals of European descent to achieve large sample sizes and control for population stratification . Furthermore, non-coding RNAs likeSNORA70 (Small Nucleolar RNA, H/ACA Box 70) and RN7SL734P play regulatory roles in gene expression and RNA processing; rs7307780 could affect their stability or function, indirectly influencing protein synthesis or cellular stress responses crucial for cardiac resilience and protection against sudden cardiac arrest.^[7] ZNF385B (Zinc Finger Protein 385B) functions as a transcription factor, controlling the expression of genes involved in cell differentiation, growth, and apoptosis, all of which are vital for maintaining healthy cardiac tissue. The variant rs16866933 could influence its DNA-binding specificity or transcriptional activation, leading to altered gene expression patterns that may affect myocardial integrity or function. RAB3GAP1 (RAB3 GTPase activating protein 1) and ZRANB3 (Zinc finger RANBP2-type containing 3) are involved in fundamental cellular processes, with RAB3GAP1 playing a role in membrane trafficking and ZRANB3 in DNA repair pathways. Variations like rs6730157 could perturb these essential cellular mechanisms, impacting the heart’s ability to repair damage or manage intracellular transport, which are critical for preventing cellular dysfunction that can lead to arrhythmias.^[9] Moreover, MAML2(Mastermind-like transcriptional coactivator 2) is a key coactivator in the Notch signaling pathway, which is indispensable for proper cardiovascular development and regulation of adult cardiac function. The variantrs10765792 near MAML2 has been associated with influencing atrioventricular conduction, a critical aspect of the heart’s electrical system.^[10] ZNF365 (Zinc Finger Protein 365) is a protein implicated in DNA repair and cell cycle regulation, essential processes for maintaining genomic stability and preventing uncontrolled cell growth or death in cardiac cells. A variant such as rs2077316 may affect the efficiency of these processes, potentially contributing to cellular stress or damage in the myocardium. NGEF(Neuronal Guanine Nucleotide Exchange Factor) regulates Rho GTPases, which are crucial signaling molecules controlling the cytoskeleton, cell adhesion, and cell migration, all vital for the structural integrity and electrical coupling of cardiac muscle.rs1554218 could alter NGEF’s activity, thereby impacting these fundamental cellular dynamics in the heart.^[11] Furthermore, GRIA1(Glutamate Ionotropic Receptor AMPA Type Subunit 1) encodes a component of AMPA receptors, which while primarily neuronal, also have roles in cardiac tissue where they might modulate excitability. The variantrs12189362 could affect the function or expression of these receptors, potentially influencing cardiac electrical properties. Lastly, KCTD1(Potassium Channel Tetramerization Domain Containing 1) is involved in protein interactions, potentially impacting ion channel assembly or regulation, which are fundamental to cardiac electrical activity.rs16942421 might modify these interactions, subtly altering cardiac electrophysiology and contributing to susceptibility to arrhythmias and sudden cardiac arrest.^[12]

Causes

Sudden cardiac arrest (SCA) is a complex medical emergency resulting from a sudden, unexpected loss of heart function, breathing, and consciousness. Its etiology is multifactorial, involving a delicate interplay of genetic predispositions, underlying cardiac pathologies, and environmental triggers. Understanding these causal factors is crucial for risk assessment and prevention.

Genetic Predisposition to Arrhythmias

A significant genetic component contributes to the risk of sudden cardiac arrest, with family history being a recognized risk factor for both sudden cardiac death and primary cardiac arrest.^[7] Heritability studies have shown relative risks of 1.5 to 2 for sudden cardiac death within families.^[7] This genetic influence extends to both rare Mendelian forms, such as inherited channelopathies and cardiomyopathies, and more common polygenic risks involving multiple genetic variants.^[1]For instance, common variants in cardiac ion channel genes, including those influencing QT interval duration, have been associated with sudden cardiac death, as have genetic variations in the nitric oxide synthase 1 adaptor protein (NOS1AP).^[4]Furthermore, genome-wide association studies have identified susceptibility loci, such as one at 21q21, for ventricular fibrillation in acute myocardial infarction.^[13] Gene-gene interactions, where the effects of one gene are modified by another, can also contribute to the overall arrhythmic risk, influencing the severity and penetrance of inherited cardiac conditions.^[14]

Structural Heart Disease and Comorbidities

The most prevalent underlying cause of sudden cardiac arrest is structural heart disease, with approximately 80% of affected individuals having underlying coronary artery disease.^[7] This often manifests as myocardial infarction, which can create areas of scar tissue in the heart, disrupting normal electrical pathways and predisposing to life-threatening arrhythmias.^[15]Other significant comorbidities include heart failure, where the weakened heart muscle is more prone to electrical instability, increasing the risk of ventricular arrhythmias and subsequent cardiac arrest.^[16]Age-related changes in cardiac structure and function, such as fibrosis and decline in pacemaker cell function, can further exacerbate these risks, making older individuals more susceptible to various arrhythmias that can culminate in sudden cardiac arrest.

Environmental and Lifestyle Influences

Environmental factors and lifestyle choices play a critical role, often interacting with genetic predispositions to trigger sudden cardiac arrest. Poor lifestyle habits, including an unhealthy diet, lack of physical activity, and smoking, contribute to the development and progression of coronary artery disease and other cardiovascular conditions that are primary drivers of SCA. Exposure to environmental pollutants, such as ambient particulate air pollution, has been linked to increased ectopy, which can precede more severe arrhythmias.^[17]Additionally, certain medications can induce cardiac arrhythmias as a side effect, such as theophylline toxicity leading to cardiac arrhythmias.^[18]The cumulative effect of these environmental stressors, particularly in individuals with a genetic susceptibility, can lower the threshold for developing critical arrhythmias, leading to sudden cardiac arrest.

Biological Background

Sudden cardiac arrest (SCA) is a critical medical emergency characterized by an abrupt loss of heart function, breathing, and consciousness, typically resulting from a severe electrical disturbance in the heart. This life-threatening event accounts for over 300,000 deaths annually in the United States, with approximately 80% of affected individuals having underlying coronary artery disease.^[7] The biological underpinnings of SCA are complex, involving intricate interactions between cardiac electrophysiology, genetic predispositions, and broader pathophysiological processes.

Cardiac Electrophysiology: The Basis of Heart Rhythm Disorders

The heart’s ability to pump blood effectively relies on a precise electrical conduction system, and disruptions to this system are central to sudden cardiac arrest. At the cellular level, the coordinated movement of ions across cardiomyocyte membranes through specialized cardiac ion channels generates electrical impulses, dictating the heart’s rhythm. Key biomolecules, such as sodium channels, calcium channels, and potassium channels, are critical proteins that govern the depolarization and repolarization phases of the cardiac action potential, which are essential for maintaining a regular heartbeat.^[4] When these channels malfunction due to genetic mutations or other factors, the heart’s electrical stability is compromised, leading to life-threatening arrhythmias like ventricular fibrillation.^[13]Electrophysiological measurements, such as the QT interval on an electrocardiogram, serve as vital indicators of cardiac repolarization, the process by which heart cells reset their electrical charge after each beat. Variability in the QT interval, either prolonged or shortened, is a known marker for sudden cardiac death in individuals with congenital syndromes, drug-induced effects, or following a myocardial infarction.^[10] Another important measure is the PR interval, representing the time taken for electrical impulses to travel from the atria to the ventricles, with a normal range typically between 120 and 206 milliseconds.^[10] Genetic variants in genes like NOS1AP(nitric oxide synthase 1 adaptor protein) have been consistently associated with changes in QT interval duration and have been implicated as predictors of sudden cardiac death in various populations.^[5]

Genetic Architecture of Sudden Cardiac Arrest

A significant genetic component underlies susceptibility to sudden cardiac arrest, as evidenced by family history being a notable risk factor with relative risks ranging from 1.5 to 2.^[7] Genome-wide association studies (GWAS) and other genetic analyses have identified numerous genetic mechanisms contributing to this heritability, including specific gene functions, regulatory elements, and gene expression patterns.^[3] For instance, common variants in cardiac ion channel genes are strongly associated with sudden cardiac death, highlighting the direct link between genetic makeup and cardiac electrical stability.^[4]Specific genes have been identified as crucial players in the genetic predisposition to arrhythmias. Variants in the cardiac sodium channel gene,SCN5A, are associated with various cardiac conditions, including atrial fibrillation, sudden cardiac death in women, and even congenital sick sinus syndrome when recessive mutations are present.^[19]Furthermore, a susceptibility locus at 21q21 has been identified through GWAS for ventricular fibrillation in acute myocardial infarction.^[13]Beyond single nucleotide polymorphisms (SNPs), copy number variations (CNVs) have also been explored, indicating that larger structural genomic changes may also contribute to the risk of life-threatening arrhythmias.^[7]

Pathophysiological Contexts and Systemic Influences

Sudden cardiac arrest often occurs in the context of underlying cardiac conditions and broader systemic disruptions, underscoring the interplay between tissue and organ-level biology and homeostatic balance. Coronary artery disease is a predominant underlying factor, contributing to approximately 80% of SCA cases, suggesting that structural heart disease often precedes the electrical instability.^[7]Myocardial infarction, a severe form of coronary artery disease, is also a significant risk factor, with QT interval variability frequently observed post-infarction and contributing to the risk of sudden cardiac death.^[10]Beyond structural heart disease, other pathophysiological processes and systemic factors can influence the risk of arrhythmias. For example, some individuals present with a distinct clinical entity involving ST-segment elevation, short QT intervals, and sudden cardiac death, which has been linked to specific calcium channel dysfunction.^[20] Environmental factors, such as ambient particulate air pollution, have also been associated with arrhythmogenesis, leading to increased ectopy (premature heartbeats).^[21]Additionally, metabolic disturbances, drug toxicities like those from theophylline, and even the levels of circulating biomolecules such as B-type natriuretic peptide can influence the occurrence of ventricular arrhythmias, demonstrating the complex web of interactions that can culminate in sudden cardiac arrest.^[21]

Molecular Signaling and Calcium Homeostasis

The intricate balance of intracellular signaling pathways is crucial for maintaining normal cardiac function. Platelet-derived growth factor (PDGF) signaling, for instance, plays a significant role in regulating cellular calcium stores.^[22] This process typically involves a nonclustering mechanism of the Orai1 channel, which is essential for precise calcium modulation within cells. However, when the endoplasmic reticulum (ER) experiences stress, PDGF stimulation can lead to Orai1 clustering, potentially disrupting calcium homeostasis and contributing to cellular dysfunction.^[22] Such ER stress itself can profoundly influence gene expression and cellular responses, indicating a dynamic feedback loop that links ER health to critical signaling cascades and overall cardiac cell viability .

Protein Quality Control and Degradation

The Ubiquitin Proteasome System (UPS) represents a fundamental regulatory mechanism, critical for maintaining proteostasis and implicated in the pathogenesis of cardiovascular diseases. Dysregulation of the UPS, characterized by increased activity, has been observed in conditions such as human carotid atherosclerosis, where it is associated with heightened inflammation and contributes to the destabilization of atherosclerotic plaques.^[23] This complex system relies on the precise action of E3 ligases, such as Fbxo25, which specifically target and facilitate the degradation of cardiac-specific transcription factors, thereby exerting tight control over gene expression vital for cardiac development and function.^[24] Complementing this, ubiquitin-specific deubiquitinases (DUBs) regulate the UPS by cleaving ubiquitin chains from target proteins, influencing protein stability and turnover, while components like SGT1 function as integral subunits of SCF ubiquitin ligase complexes, underscoring the sophisticated post-translational control governing protein fate in the heart.^[25]

Cardiac Energy Metabolism and Substrate Utilization

Maintaining robust cardiac function is critically dependent on highly efficient and adaptable energy metabolism, with the heart proficiently utilizing various substrates for fuel.^[26]Disturbances in these metabolic pathways can predispose individuals to cardiovascular pathologies, including heart failure and, consequently, sudden cardiac arrest. For example, the synthesis of dicarboxylic acylcarnitines is an essential aspect of lipid metabolism, providing a significant energy source for myocardial cells.^[27]Any impairment in the flux control of these metabolic pathways can precipitate energetic myocardial stress and oxidative stress, which are recognized as crucial contributors to the progression of heart failure.^[28] Furthermore, genes such as SLC27A6have been identified as potentially important in left ventricular hypertrophy, suggesting a role in fatty acid transport or utilization that, when compromised, can lead to maladaptive cardiac remodeling and severe energy imbalance.^[29]

Genetic and Systemic Dysregulation in Cardiac Disease

Sudden cardiac arrest frequently stems from a complex interplay of inherited genetic predispositions and systemic pathway dysregulation, manifesting as emergent properties of intricate network interactions within the cardiovascular system. Genome-wide association studies have successfully identified numerous genetic variants associated with an increased risk of incident heart failure and with variations in cardiac structure and function, highlighting the significant genetic regulatory component underlying cardiac health.^[19] For instance, specific genes including MYRIP and TRAPPC11have been linked to left ventricular hypertrophy, where their dysregulation contributes to pathological cardiac remodeling.^[29]The integration of metabolomic quantitative trait loci (mQTL) mapping further underscores the involvement of systems such as the Ubiquitin Proteasome System in cardiovascular disease pathogenesis, illustrating how genetic variations can profoundly impact metabolic and proteomic networks, leading to compensatory mechanisms that may eventually fail, thereby increasing susceptibility to sudden cardiac events.^[23]

Genetic Variations in Cardiac Drug Targets

Genetic variants in cardiac ion channel genes, such as KCNQ1 and SCN5A, have been found to be associated with sudden cardiac death and prolonged QT duration.^[30] These specific ion channels are fundamental to cardiac electrical activity and represent crucial targets for various antiarrhythmic medications used in the management and prevention of life-threatening arrhythmias. Similarly, genetic variations within the nitric oxide synthase 1 adaptor protein (NOS1AP) are linked to sudden cardiac death and also influence the QT interval duration.^[5] These findings underscore how inherited differences in proteins that serve as drug targets or modulate related signaling pathways could influence an individual’s therapeutic response to cardiac interventions.

Pharmacodynamic Effects on Cardiac Repolarization

Common genetic variants across at least ten genomic loci have been identified that influence the duration of the QT interval.^[6]The QT interval, a critical electrocardiographic measure of cardiac repolarization, is a significant pharmacodynamic endpoint for numerous cardiovascular medications, as its prolongation can increase the risk of torsades de pointes and other life-threatening arrhythmias. Variability in these genetic loci suggests a predisposition to altered cardiac electrical stability, which could impact the efficacy and safety profile of drugs designed to modulate cardiac rhythm. Understanding these genetic influences on baseline cardiac electrophysiology is therefore valuable for anticipating individual variability in response to drugs that affect repolarization.

Key Variants

RS ID	Gene	Related Traits
rs12429889	KLF12 - LINC00402	sudden cardiac arrest
rs4665058	BAZ2B	sudden cardiac arrest
rs7307780	SNORA70 - RN7SL734P	sudden cardiac arrest
rs16866933	ZNF385B	sudden cardiac arrest
rs6730157	RAB3GAP1, ZRANB3	gut microbiome sudden cardiac arrest neurofibrillary tangles docosahexaenoic acid
rs10765792	MAML2	sudden cardiac arrest
rs2077316	ZNF365	sudden cardiac arrest
rs1554218	NGEF	sudden cardiac arrest
rs12189362	GRIA1	sudden cardiac arrest
rs16942421	KCTD1	sudden cardiac arrest

Frequently Asked Questions About Sudden Cardiac Arrest

These questions address the most important and specific aspects of sudden cardiac arrest based on current genetic research.

---

1. My family has a history of sudden heart issues; am I at high risk too?

Yes, a family history of sudden cardiac death or arrest is a recognized risk factor. Studies show a significant heritability, meaning your risk could be 1.5 to 2 times higher than someone without such a history. This suggests a genetic predisposition passed down through families.

2. Could a DNA test tell me if I’m at risk for sudden cardiac arrest?

Genetic research has identified specific variants in genes like KCNQ1, SCN5A, and NOS1APthat are associated with sudden cardiac arrest. While a DNA test can identify some of these variants, the full picture of your personal risk is complex and involves many genetic and lifestyle factors. It’s best discussed with a genetics expert or cardiologist.

3. I’m not European; does that change my heart risk understanding?

Yes, it can. Much of the genetic research on sudden cardiac arrest has focused on individuals of European descent. This means that genetic variants identified in these studies might not have the same effects or even be present in other ancestral groups due to differences in genetic diversity. More research is needed across diverse populations for a complete understanding.

4. Why do some healthy-looking people suddenly collapse from a heart issue?

Often, these sudden collapses are due to severe electrical disturbances in the heart, called life-threatening arrhythmias, which stop its pumping function. While some people have underlying coronary artery disease, a significant genetic contribution can also predispose individuals to these electrical problems, even if they appear otherwise healthy.

5. Can I prevent sudden cardiac arrest even with a family history?

While you can’t change your genetic makeup, understanding your family history is crucial for prevention. If you’re identified as high-risk, doctors can monitor your heart’s electrical activity, like your QT duration, and discuss preventative strategies. For very high-risk individuals, implantable cardioverter-defibrillators (ICDs) are a key intervention to correct dangerous rhythms.

6. What are the early signs if I have a genetic predisposition to this?

Sudden cardiac arrest often has no warning signs immediately before the event, as it’s an abrupt electrical malfunction. However, a key indicator of cardiac electrical activity that can be measured is your QT duration. If you have a genetic predisposition, your doctor might monitor this and other heart measurements, even if you feel fine.

7. If I have heart disease, does my family history matter more for SCA risk?

Both factors are important. While about 80% of SCA cases involve underlying coronary artery disease, a strong family history significantly increases your risk independently. If you have both, it suggests a compounded risk, where genetic factors might interact with your existing heart condition to increase vulnerability to dangerous arrhythmias.

8. Is my heart’s electrical rhythm tied to my genetics?

Absolutely. The timing of your heart’s electrical activity, like the QT duration, is significantly influenced by your genetics. Variants in genes controlling cardiac ion channels, such as KCNQ1 and SCN5A, play a direct role in how your heart repolarizes after each beat, which can affect its rhythm and stability.

9. If I’m high-risk, what preventative options do I have?

For individuals identified as high-risk, often based on factors like diminished ejection fraction, symptomatic heart failure, or prolonged QRS interval, implantable cardioverter-defibrillators (ICDs) are a primary intervention. These devices can detect and correct life-threatening arrhythmias, significantly improving outcomes.

10. Why is it so hard to figure out who is at risk for sudden cardiac arrest?

It’s challenging because SCA is influenced by many factors, and genetic studies face limitations. Research often focuses on specific populations, making findings hard to apply broadly, and the precise definition of heart traits can vary. Also, even when genetic associations are found, it’s difficult to pinpoint the exact causal variant among many common genetic differences.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Sen-Chowdhry, S., and W. J. McKenna. “Sudden cardiac death in the young: the impact of inherited cardiovascular disease.”Textbook of Cardiovascular Medicine, CD/online content ed., Lippincott Williams and Wilkins Press, 2007.

[2] Jouven, X., et al. “Predicting sudden death in population: Paris prospective study I.” Circulation, vol. 99, 1999, pp. 1978–1983.

[3] Knollmann, B. C., and D. M. Roden. “A genetic framework for improving arrhythmia therapy.” Nature, vol. 451, 2008, pp. 929–936.

[4] Albert, C. M., et al. “Cardiac sodium channel gene variants and sudden cardiac death in women.”Circulation, vol. 117, 2008, pp. 16–23.

[5] Kao, W. H. Linda, et al. “Genetic Variations in Nitric Oxide Synthase 1 Adaptor Protein Are Associated With Sudden Cardiac Death in US White Community-Based Populations.” Circulation, vol. 119, no. 7, 2009, pp. 940–951.

[6] Newton-Cheh, C., et al. “Common variants at ten loci influence QT interval duration in the QTGEN Study.”Nat Genet, vol. 41, 2009, pp. 399–406.

[7] Murray SS. “Genome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmias.” PLoS One, 2012. PMID: 22247754.

[8] Noseworthy, P. A., and C. Newton-Cheh. “Genetic determinants of sudden cardiac death.” Circulation, vol. 118, 2008, pp. 1854–1863.

[9] Agopian AJ. “Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.” Circ Cardiovasc Genet, 2018. PMID: 28468790.

[10] Denny JC. “Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science.” Circulation, 2010. PMID: 21041692.

[11] Wain LV. “Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.”Nat Genet, 2011. PMID: 21909110.

[12] Sotoodehnia, N., et al. “Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.” Nat Genet, vol. 42, no. 12, Dec. 2010, pp. 1068-76. PMID: 21076409.

[13] Bezzina, C. R., et al. “Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction.”Nat Genet, vol. 42, 2010, pp. 688–691.

[14] Darbar, D., et al. “Familial atrial fibrillation is a genetically heterogeneous disorder.” J Am Coll Cardiol, vol. 41, 2003, pp. 2185–2192.

[15] Myerburg, R. J. “Implantable cardioverter-defibrillators after myocardial infarction.” N Engl J Med, vol. 359, 2008, pp. 2245–2253.

[16] Desai, Hrishikesh, et al. “Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.”Am J Cardiol, vol. 105, 2010, pp. 1336–1338.

[17] Liao, D., et al. “Ambient particulate air pollution and ectopy–the environmental epidemiology of arrhythmogenesis in Women’s Health Initiative Study, 1999-2004.” J Toxicol Environ Health A, vol. 72, 2009, pp. 30–38.

[18] Napier, Mark D., and Michael D. Cohen. “Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study.”CHEST Journal, vol. 98, 1990, pp. 672–678.

[19] Smith NL, et al. “Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.”Circulation: Cardiovascular Genetics, vol. 7, no. 3, 2014, pp. 265-273.

[20] Levy, D., et al. “Genome-wide association study of blood pressure and hypertension.”Nat Genet, 2009.

[21] Napier, M. D., et al. “Genome-wide association study and meta-analysis identify loci associated with ventricular and supraventricular ectopy.”Sci Rep, vol. 8, no. 1, Apr. 2018, p. 5569. PMID: 29618737.

[22] McKeown L, et al. “Platelet-derived growth factor maintains stored calcium through a nonclustering Orai1 mechanism but evokes clustering if the endoplasmic reticulum is stressed.” Molecular and Cellular Biology, vol. 32, no. 23, 2012, pp. 4880-4890.

[23] Kraus WE, et al. “Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis.”PLoS Genet, vol. 11, no. 11, 2015, p. e1005534.

[24] Jang JW, et al. “A novel Fbxo25 acts as an E3 ligase for destructing cardiac specific transcription factors.” Biochemical and Biophysical Research Communications, vol. 405, no. 3, 2011, pp. 419-424.

[25] Reyes-Turcu FE, Ventii KH, Wilkinson KD. “Regulation and cellular roles of ubiquitin-specific deubiquitinases.” Annual Review of Biochemistry, vol. 78, 2009, pp. 363-402.

[26] Pascual F, Coleman RA. “Fuel availability and fate in cardiac metabolism: a tale of two substrates.” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1861, no. 10, 2016, pp. 1425-1433.

[27] Johnson DW. “Synthesis of dicarboxylic acylcarnitines.” Chemistry and Physics of Lipids, vol. 129, no. 2, 2004, pp. 109-119.

[28] Scolletta S, Biagioli B. “Energetic myocardial metabolism and oxidative stress: let’s make them our friends in the fight against heart failure.”Heart Failure Reviews, vol. 15, no. 6, 2010, pp. 647-657.

[29] Irvin MR, et al. “Whole-Exome Sequencing and hiPSC Cardiomyocyte Models Identify MYRIP, TRAPPC11, and SLC27A6of Potential Importance to Left Ventricular Hypertrophy in an African Ancestry Population.”Frontiers in Genetics, vol. 12, 2021, p. 627197.

[30] Albert, C. M., et al. “Common variants in cardiac ion channel genes are associated with sudden cardiac death.” Circ Arrhythm Electrophysiol, vol. 3, 2010, pp. 222–229.